146 related articles for article (PubMed ID: 18278856)
1. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
[TBL] [Abstract][Full Text] [Related]
2. New strongylophorines from the Okinawan marine sponge Petrosia (Strongylophora) corticata.
Hoshino A; Mitome H; Miyaoka H; Shintani A; Yamada Y; van Soest RW
J Nat Prod; 2003 Dec; 66(12):1600-5. PubMed ID: 14695804
[TBL] [Abstract][Full Text] [Related]
3. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
4. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
5. (Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors.
Lee K; Lee JH; Boovanahalli SK; Jin Y; Lee M; Jin X; Kim JH; Hong YS; Lee JJ
J Med Chem; 2007 Apr; 50(7):1675-84. PubMed ID: 17328532
[TBL] [Abstract][Full Text] [Related]
6. Strongylophorines, meroditerpenoids from the marine sponge Petrosia corticata, function as proteasome inhibitors.
Noda A; Sakai E; Kato H; Losung F; Mangindaan RE; de Voogd NJ; Yokosawa H; Tsukamoto S
Bioorg Med Chem Lett; 2015 Jul; 25(13):2650-3. PubMed ID: 25987373
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor 1 inhibitors.
Melillo G
Methods Enzymol; 2007; 435():385-402. PubMed ID: 17998065
[TBL] [Abstract][Full Text] [Related]
8. Strongylophorine-26, a new meroditerpenoid isolated from the marine sponge Petrosia (Strongylophora) corticata that exhibits anti-invasion activity.
Warabi K; McHardy LM; Matainaho L; Van Soest R; Roskelley CD; Roberge M; Andersen RJ
J Nat Prod; 2004 Aug; 67(8):1387-9. PubMed ID: 15332859
[TBL] [Abstract][Full Text] [Related]
9. Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1.
Dat NT; Jin X; Lee JH; Lee D; Hong YS; Lee K; Kim YH; Lee JJ
J Nat Prod; 2007 Jul; 70(7):1093-7. PubMed ID: 17583950
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
Xia Y; Jin Y; Kaur N; Choi Y; Lee K
Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax.
Ji DB; Zhu MC; Zhu B; Zhu YZ; Li CL; Ye J; Zhu HB
J Cardiovasc Pharmacol; 2008 Aug; 52(2):191-202. PubMed ID: 18670359
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening identifies CHMP4A associated with hypoxia-inducible factor 1.
Shi T; Dong Y; Li J; Gao P; Fu D; Ma D
Life Sci; 2010 Nov; 87(19-22):604-8. PubMed ID: 20888838
[TBL] [Abstract][Full Text] [Related]
13. Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.
Cho H; Lee HY; Ahn DR; Kim SY; Kim S; Lee KB; Lee YM; Park H; Yang EG
Mol Pharmacol; 2008 Jul; 74(1):70-81. PubMed ID: 18426858
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
[TBL] [Abstract][Full Text] [Related]
15. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
16. Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.
Verheul HM; Salumbides B; Van Erp K; Hammers H; Qian DZ; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2008 Jun; 14(11):3589-97. PubMed ID: 18519793
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress in the study on antitumor drugs targeting hypoxia-inducible factor-1].
Wang JJ; Li J; Geng MY
Yao Xue Xue Bao; 2008 Jun; 43(6):565-9. PubMed ID: 18822956
[TBL] [Abstract][Full Text] [Related]
18. The intravenous anesthetics barbiturates inhibit hypoxia-inducible factor 1 activation.
Wakamatsu T; Tanaka T; Oda S; Nishi K; Harada H; Daijo H; Takabuchi S; Kai S; Fukuda K; Hirota K
Eur J Pharmacol; 2009 Sep; 617(1-3):17-22. PubMed ID: 19595685
[TBL] [Abstract][Full Text] [Related]
19. Laurenditerpenol, a new diterpene from the tropical marine alga Laurenciaintricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells.
Mohammed KA; Hossain CF; Zhang L; Bruick RK; Zhou YD; Nagle DG
J Nat Prod; 2004 Dec; 67(12):2002-7. PubMed ID: 15620241
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF).
Han ZB; Ren H; Zhao H; Chi Y; Chen K; Zhou B; Liu YJ; Zhang L; Xu B; Liu B; Yang R; Han ZC
Carcinogenesis; 2008 Oct; 29(10):1853-61. PubMed ID: 18339685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
